Related Experiment Video
Updated: Aug 14, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
PFO Closure for Cryptogenic Stroke
Sabreena J Gillow1, Vivien H Lee
1Department of Neurological Sciences, Section of Cerebrovascular Disease, Rush University Medical Center, 1725 W. Harrison St #1121, Chicago, IL, 60612, USA, Sabreena_J_Gillow@rush.edu.
Abstract:
A patent foramen ovale (PFO) is a common finding in the general population and has been theorized to be a mechanism for ischemic stroke primarily due to a deep venous thrombus embolizing through the shunt into the arterial circulation. There has been much debate regarding the association between PFO and stroke, especially in the case of a cryptogenic stroke (i.e., stroke of unknown etiology) in a younger patient without other risk factors. Traditionally, when a PFO is detected, antithrombotic therapy to mitigate risk of a future ischemic event has been the mainstay of treatment. More recently, both surgical and transcatheter closure of a PFO have been widely utilized. However, there are only few randomized controlled trials assessing the efficacy of PFO closure for stroke prevention.
Insights
Patent foramen ovale (PFO) is linked to cryptogenic stroke. While closure is common, few trials assess its effectiveness in preventing future ischemic events.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Patent foramen ovale (PFO) is a common cardiac anomaly.
- PFO is a potential pathway for paradoxical embolism causing ischemic stroke.
- The association between PFO and cryptogenic stroke remains debated, particularly in younger patients.
Purpose of the Study:
- To review the current understanding of PFO as a mechanism for ischemic stroke.
- To discuss the evolving treatment strategies for PFO, including closure interventions.
- To highlight the limited evidence from randomized controlled trials on PFO closure efficacy for stroke prevention.
Main Methods:
- Literature review of studies investigating PFO and stroke.
- Analysis of traditional and contemporary treatment approaches for PFO.
- Assessment of the existing randomized controlled trial data on PFO closure.
Main Results:
- PFO is frequently found in the general population.
- Antithrombotic therapy has been the traditional management for PFO-associated stroke risk.
- Transcatheter and surgical PFO closure are increasingly used, but robust trial data is scarce.
Conclusions:
- The role of PFO in cryptogenic stroke is still under investigation.
- Further high-quality randomized controlled trials are needed to establish the efficacy of PFO closure for stroke prevention.
- Evidence-based guidelines for PFO management in stroke patients require strengthening.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

